Samim Enayat, MD
NPI 1700053824 · Endocrinology, Diabetes & Metabolism Physician · Fairfax, VA
Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Samim Enayat, MD is a Endocrinology, Diabetes & Metabolism Physician provider in Fairfax, VA (NPI 1700053824).
Provider details
- NPI number
- 1700053824
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 0101250139 (VA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
1,385 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 741 | $84 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 319 | $127 |
| Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223 | 155 | $185 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 64 | $116 |
| Subsequent Hospital Care With Straightforward Or Low Level of Medical Decision Making, Per Day, If Using Time, at Least 25 Minutes99231 | 46 | $53 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Semaglutidebrand: Ozempic | 27 | 13 |
| Metformin Hcl | 16 | — |
| Insulin Glargine,hum.rec.anlogbrand: Lantus Solostar | 11 | — |
| Levothyroxine Sodium | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$13,684 across 20 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 10105 Banburry Cross Dr Ste 130Las Vegas, NV 89144Phone: (615) 879-0587
- 3300 Gallows RdFalls Church, VA 22042-3307Phone: (703) 776-4001Fax: (703) 776-7113
Registry dates
- Enumerated
- 2008-05-08
- Last updated
- 2022-01-10
- Certified
- 2022-01-10
Frequently asked questions
- What is Samim Enayat's NPI number?
- Samim Enayat's National Provider Identifier (NPI) is 1700053824, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Samim Enayat's specialty?
- Samim Enayat is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
- Where is Samim Enayat located?
- Samim Enayat's practice location on file with NPPES is 8081 Innovation Park Dr Ste 301, Fairfax, VA 22031-4867.
- What is Samim Enayat's phone number?
- The practice phone number listed in the NPPES registry for Samim Enayat is (877) 511-4625.
- Does Samim Enayat accept Medicare?
- Samim Enayat is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Samim Enayat's NPI active?
- Yes — Samim Enayat's NPI (1700053824) is active in the NPPES registry as of the last update on 2022-01-10.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.